# US 2019/0291113 A1 · Methods and systems for conducting a chemical or biological reaction

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0291113 A1
- Document ID: US20190291113A1
- Status: Published application
- Kind: A1
- Application number: 16/368,028
- Filed: 2019-03-28
- Published: 2019-09-26
- Earliest claimed: 2016-11-10
- Assignees: Coyote Bioscience Co., Ltd.
- Applicants: Coyote Bioscience Co., Ltd.
- Inventors: Jesus Ching; Phillip You Fai Lee; Chen Li; Lingguo Du
- Web page: https://patentgrep.com/patent/US20190291113A1

## CPC

- B01L 3/502784: {specially adapted for droplet or plug flow, e.g. digital microfluidics}
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/70: involving virus or bacteriophage {(immunoassay for viruses G01N33/56983)}
- B01L 2300/123: Flexible; Elastomeric
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present disclosure provides methods and systems for analyzing nucleic acids and for conducting chemical and/or biological reactions. Methods and system for droplet generation, guidance, and isolation are also provided.

## Claims

### Claim 1

A method for facilitating a chemical or biological reaction on a biological sample, comprising:
subjecting a first fluid phase to flow along a fluid flow path, through at least one opening in a membrane, to a chamber downstream of said membrane, wherein said membrane intersects said fluid flow path, and wherein said membrane is flexible;
subjecting a second fluid phase to flow along said fluid flow path through said at least one opening in said membrane to said chamber, which chamber comprises said first fluid phase that is immiscible with said second fluid phase, wherein said second fluid phase comprises said biological sample or a portion of said biological sample; and
generating a plurality of droplets in said chamber upon said second fluid phase coming in contact with said first fluid phase, wherein a given droplet of said plurality of droplets comprises said biological sample and reagents necessary for said chemical or biological reaction.

### Claim 2 (depends on 1)

The method of claim 1, wherein said first fluid phase and/or said second fluid phase is directed using a flow controller, a positive pressure or a negative pressure.

### Claim at position 3

-4. (canceled)

### Claim 5 (depends on 1)

The method of claim 1, wherein said first or second fluid phase comprises reagents necessary for the chemical or biological reaction.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The method of claim 1, wherein said chemical or biological reaction is nucleic acid amplification, and wherein said reagents include one or more primers and polymerizing enzyme.

### Claim 8 (depends on 7)

The method of claim 7, wherein said nucleic acid amplification is polymerase chain reaction (PCR).

### Claim 9

(canceled)

### Claim 10 (depends on 7)

The method of claim 7, further comprising subjecting said given droplet to nucleic acid amplification under conditions necessary to generate amplification product(s) from said biological sample in said given droplet.

### Claim at position 10

-12. (canceled)

### Claim 13 (depends on 7)

The method of claim 7, wherein said biological sample comprises a virus.

### Claim at position 12

-15. (canceled)

### Claim 16 (depends on 13)

The method of claim 13, wherein said virus is selected from the group consisting of human immunodeficiency virus I (HIV I), human immunodeficiency virus II (HIV II), an orthomyxovirus, Ebola virus, Dengue virus, influenza viruses, herpesvirus, hepatitis A virus, hepatitis B virus, hepatitis C virus, hepatitis D virus, hepatitis E virus, hepatitis G virus, Epstein-Barr virus, mononucleosis virus, cytomegalovirus, SARS virus, West Nile Fever virus, polio virus, measles virus, herpes simplex virus, smallpox virus, adenovirus, Coxsackie virus, papillomavirus, zika virus, and Varicella virus.

### Claim at position 14

-20. (canceled)

### Claim 21 (depends on 7)

The method of claim 7, wherein said biological sample comprises a pathogenic bacterium or a pathogenic protozoan.

### Claim 22

(canceled)

### Claim 23 (depends on 21)

The method of claim 21, wherein said pathogenic bacterium is selected from the group consisting of Staphylococcus aureus, Listeria monocytogenes, Escherichia coli, Enterobacter sakazakii, Vibrio Parahemolyticus, and Shigella spp, Mycobacterium tuberculosis, Plasmodium, and Salmonella

### Claim at position 18

-26. (canceled)

### Claim 27 (depends on 1)

The method of claim 1, further comprising detecting said amplification product(s) in said given droplet.

### Claim 28 (depends on 1)

The method of claim 1, further comprising monitoring a temperature of a solution comprising said plurality of droplets.

### Claim 29

(canceled)

### Claim 30 (depends on 1)

The method of claim 1, wherein each of said plurality of droplets has a droplet size from about 0.1 micrometers to about 200 micrometers.

### Claim at position 23

-35. (canceled)

### Claim 36 (depends on 1)

The method of claim 1, wherein said first fluid phase comprises an oil.

### Claim 37 (depends on 36)

The method of claim 36, wherein said first fluid phase comprises a surfactant.

### Claim at position 26

-39. (canceled)

### Claim 40 (depends on 1)

The method of claim 1, further comprising subjecting said chamber to vibration.

### Claim at position 28

-43. (canceled)

### Claim 44 (depends on 1)

The method of claim 1, wherein said membrane includes a lipid bilayer.

### Claim 45 (depends on 1)

The method of claim 1, wherein said at least one opening includes a pore protein.

### Claim 46 (depends on 45)

The method of claim 45, wherein said pore protein is alpha hemolysin or a variant thereof.

### Claim 47

A system for conducting a chemical or biological reaction on a biological sample, comprising:
a fluid flow path in fluid communication with a chamber downstream of a membrane, wherein said membrane comprises at least one opening and intersects said fluid flow path, and wherein said membrane is flexible;
a controller comprising one or more computer processors that are individually or collectively programmed to:
(i) subject a first fluid phase to flow along said fluid flow path, through said at least one opening in said membrane, to said chamber downstream of said membrane;
(ii) subject a second fluid phase to flow along said fluid flow path through said at least one opening in said membrane to said chamber, which chamber comprises said first fluid phase that is immiscible with said second fluid phase, wherein said second fluid phase comprises said biological sample or a portion of said biological sample; and
(iii) generate a plurality of droplets in said chamber upon said second fluid phase coming in contact with said first fluid phase,
wherein a given droplet of said plurality of droplets comprises said biological sample and reagents necessary for said chemical or biological reaction.

### Claim at position 33

-88. (canceled)
